T1/ST2 is an orphan receptor of unknown function that is expressed on the surface of murine T helper cell type 2 (Th2), but not Th1 effector cells. In vitro blockade of T1/ST2 signaling with an immunoglobulin (Ig) fusion protein suppresses both differentiation to and activation of Th2, but not Th1 effector populations. In a nascent Th2-dominated response, anti-T1/ST2 monoclonal antibody (mAb) inhibited eosinophil infiltration, interleukin 5 secretion, and IgE production. To determine if these effects were mediated by a direct effect on Th2 cells, we next used a murine adoptive transfer model of Th1- and Th2-mediated lung mucosal immune responses. Administration of either T1/ST2 mAb or T1/ST2-Ig abrogated Th2 cytokine production in vivo and the induction of an eosinophilic inflammatory response, but failed to modify Th1-mediated inflammation. Taken together, our data demonstrate an important role of T1/ST2 in Th2-mediated inflammatory responses and suggest that T1/ST2 may prove to be a novel target for the selective suppression of Th2 immune responses.
Skip Nav Destination
Article navigation
4 October 1999
Article|
October 04 1999
Crucial Role of the Interleukin 1 Receptor Family Member T1/St2 in T Helper Cell Type 2–Mediated Lung Mucosal Immune Responses
Anthony J. Coyle,
Anthony J. Coyle
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Clare Lloyd,
Clare Lloyd
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Jane Tian,
Jane Tian
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Trang Nguyen,
Trang Nguyen
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Christina Erikkson,
Christina Erikkson
bAstra Draco, Inflammation Pharmacology, Preclinical Research and Development, S-221 00 Lund, Sweden
Search for other works by this author on:
Lin Wang,
Lin Wang
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Par Ottoson,
Par Ottoson
bAstra Draco, Inflammation Pharmacology, Preclinical Research and Development, S-221 00 Lund, Sweden
Search for other works by this author on:
Per Persson,
Per Persson
bAstra Draco, Inflammation Pharmacology, Preclinical Research and Development, S-221 00 Lund, Sweden
Search for other works by this author on:
Tracy Delaney,
Tracy Delaney
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Sophie Lehar,
Sophie Lehar
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Steve Lin,
Steve Lin
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Louis Poisson,
Louis Poisson
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Christian Meisel,
Christian Meisel
cDeutsches Rheumaforschungs Zentrum, Berlin D-10117, Germany
dUniversitätsklinikum Charite, Rheumatologie und Klinische Immunologie, D-10098 Berlin, Germany
Search for other works by this author on:
Thomas Kamradt,
Thomas Kamradt
cDeutsches Rheumaforschungs Zentrum, Berlin D-10117, Germany
dUniversitätsklinikum Charite, Rheumatologie und Klinische Immunologie, D-10098 Berlin, Germany
Search for other works by this author on:
Torbjorn Bjerke,
Torbjorn Bjerke
bAstra Draco, Inflammation Pharmacology, Preclinical Research and Development, S-221 00 Lund, Sweden
Search for other works by this author on:
Douglas Levinson,
Douglas Levinson
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Jose Carlos Gutierrez-Ramos
Jose Carlos Gutierrez-Ramos
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Search for other works by this author on:
Anthony J. Coyle
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Clare Lloyd
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Jane Tian
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Trang Nguyen
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Christina Erikkson
bAstra Draco, Inflammation Pharmacology, Preclinical Research and Development, S-221 00 Lund, Sweden
Lin Wang
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Par Ottoson
bAstra Draco, Inflammation Pharmacology, Preclinical Research and Development, S-221 00 Lund, Sweden
Per Persson
bAstra Draco, Inflammation Pharmacology, Preclinical Research and Development, S-221 00 Lund, Sweden
Tracy Delaney
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Sophie Lehar
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Steve Lin
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Louis Poisson
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Christian Meisel
cDeutsches Rheumaforschungs Zentrum, Berlin D-10117, Germany
dUniversitätsklinikum Charite, Rheumatologie und Klinische Immunologie, D-10098 Berlin, Germany
Thomas Kamradt
cDeutsches Rheumaforschungs Zentrum, Berlin D-10117, Germany
dUniversitätsklinikum Charite, Rheumatologie und Klinische Immunologie, D-10098 Berlin, Germany
Torbjorn Bjerke
bAstra Draco, Inflammation Pharmacology, Preclinical Research and Development, S-221 00 Lund, Sweden
Douglas Levinson
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
Jose Carlos Gutierrez-Ramos
aDepartment of Biology, Inflammation Division, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139
1used in this paper: BAL, bronchoalveolar lavage; CCR, CC chemokine receptor; TLR, Toll-like receptor
Received:
March 15 1999
Revision Requested:
June 30 1999
Accepted:
July 06 1999
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 1999 The Rockefeller University Press
1999
The Rockefeller University Press
J Exp Med (1999) 190 (7): 895–902.
Article history
Received:
March 15 1999
Revision Requested:
June 30 1999
Accepted:
July 06 1999
Citation
Anthony J. Coyle, Clare Lloyd, Jane Tian, Trang Nguyen, Christina Erikkson, Lin Wang, Par Ottoson, Per Persson, Tracy Delaney, Sophie Lehar, Steve Lin, Louis Poisson, Christian Meisel, Thomas Kamradt, Torbjorn Bjerke, Douglas Levinson, Jose Carlos Gutierrez-Ramos; Crucial Role of the Interleukin 1 Receptor Family Member T1/St2 in T Helper Cell Type 2–Mediated Lung Mucosal Immune Responses. J Exp Med 4 October 1999; 190 (7): 895–902. doi: https://doi.org/10.1084/jem.190.7.895
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement